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ABSTRAK 
 
Kanser payu-dara dan kanser serviks merangkumi 30.4% dan 12% kesemua kes kanser di 
Malaysia. Oleh demikian saringan kanser organ reproduktif pada ketika wanita mendekati 
menopaus adalah penting. Kajian ini melapurkan hasil penilaian kemasukan 495 wanita 
kawasan bandar Malaysia berusia 45 tahun ke atas yang telah mengambil bahagian 
dalam projek gayahidup sihat secara sukarela. Mereka terdiri daripada 58.0% wanita 
premenopaus dan 42.0% posmenopaus dengan min umur 51.27±5.35 tahun. Lebih dua 
pertiga terdiri dari kaum Cina diikuti oleh Melayu dan India. Pada keseluruhan, calitan Pap 
abnormal didapati pada 7.6% iaitu 1.3% cervical intraepithelial neoplasia (CIN), 6.1% 
infeksi human papilloma virus (HPV) dan 0.2% atypical squmous cells of undetermined 
significances (ASCUS). Infeksi yis dan lain organisma dijumpai pada 6.9% dan 1.9% 
masing-masing. Wanita posmenopaus menunjukkan 2.8 kali ganda insiden kanser serviks 
sementara wanita premenopaus mempunyai kadar infeksi yang lebih tinggi, 11.8% lawan 
4.7% (p=0.024). Kadar infeksi HPV adalah setara pada kedua-dua kumpulan. Kajian ini 
mendapati 1.3% mengidap kanser payu-dara, 3.6% memerlukan biopsi dan 3.4% perlu 
pemantauan berkala. Wanita posmenopaus memiliki lebih mamogram abnormal 
(p<0.0005) jenis merbahaya yang memerlukan pemantauan. Akan tetapi kadar kanser 
payu-dara adalah lebih rendah pada posmenopaus berbanding kepada premenopaus, 
0.010 lawan 0.015. Hasil kajian ini telah mengenalpasti saringan aktif kanser serviks 
dikalangan wanita posmenopaus kerana kadar kanser adalah lebih tinggi. Untuk 
mengesan perubahan abnormal payu-dara, proses saringan harus bermula lebih awal, di 
kalangan wanita pre- dan posmenopaus yang berusia 45 tahun ke atas.  
 
Kata kunci:  Calitan Pap, Mamogram 
 
 
ABSTRACT  
 
Cancers of the breast and cervix made up 30.4% and 12% of all cancer cases in Malaysia. 
Thus screening for reproductive organ cancers as women approached menopause 
becomes exceedingly important. The study reports the baseline assessment tests of 495 
disease free urban Malaysian women aged 45 years and above who volunteered in a 
healthy lifestyle intervention study. The sample comprised of 58.0% premenopaused and 
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42.0% postmenopaused women with an average age of 51.27±5.35 years old. Over two 
thirds were Chinese followed by Malays and Indians. Overall, abnormal Pap smears 
were seen in 7.6% comprising of 1.3% cervical intraepithelial neoplasia (CIN), 6.1% 
human papilloma virus (HPV) infection and 0.2% atypical squmous cells of undetermined 
significances (ASCUS). Yeast and other infections were found in 6.9% and 1.9% 
respectively. Comparatively, postmenopausal women had a 2.8 fold higher cancerous 
changes whereas premenopausal women had a higher infection rate, 11.8% vs. 4.7% 
respectively (p=0.024) with comparable HPV infection rates in both. This study found 1.3% 
had breast cancer (BC) with 3.6% requiring a biopsy while 3.4% needed regular follow up. 
Postmenopaused women had more abnormal mammograms (p<0.0005) of a graver 
nature, requiring monitoring although the rate of BC was lower than the premenopaused, 
0.010 versus 0.015. The findings identified better vigorous screening for malignant 
carcinoma of the cervix in postmenopausal women as the incidence was higher. As for 
breast abnormalities, screening should begin at an earlier age, amongst pre- and 
postmenopausal women from 45 years old and above. 
 
Key Words:  Pap Smears, Mammogram 
 
 
 
INTRODUCTION  
 
In the coming decade, the global burden of 
cancer shall change as developing 
countries adopt a more westernised 
lifestyle (Parkin 1998). Cancers as a group 
in Malaysia had risen from 6.7% of all 
medically certified deaths in 1966 to 10.8% 
in 1998 (Lim 2002) with the burden of 
cancer cases approaching the pattern of 
developed countries.  
Based on the National Cancer Registry 
data, one in four Malaysians will develop 
cancer during his or her lifetime. The 
cancer burden was estimated to be of 
about 40,000 new cases per year per 
entire population (Looi et al 2004). 
Furthermore, peculiar to Malaysia, the 
overall female incidence of 148.4 per 
100,000 was higher than the male 
incidence of 118.9 per 100,000 persons. 
The ratio of male to female incidence was 
1:1.2 unlike other countries such as 
Singapore (1:0.97), United Kingdom, 
Norway (1:0.94) and Hong Kong (1:0.76) 
(NCR 2002). 
Cervical carcinoma (CC) was the third 
most frequently occurring malignancy 
worldwide. Mortality rates were much lower 
than incidence rates with an average five 
year survival of above 50% worldwide. Due 
to an earlier occurrence, the total years of 
life lost to the malignancy was substantial 
(Herrero 1996). In 1990, nearly 80% of CC 
cases were estimated to occur in 
developing countries (Parkin et al 1999). 
CC mortality rates in Malaysia declined 
from 1985 to 1993 and then increased in 
1997. In addition, the incidence of CC was 
among the highest with an overall 
incidence higher than all developed 
countries. The age standardised incidence 
rate of Chinese in Malaysia was higher 
than in China, Hong Kong, most parts of 
Asia, superceded only by some Latin 
American and African countries (NCR 
2002). In 1995, CC was the third most 
common cause of death due to solid 
tumours among females followed by 
carcinoma of the breast and the respiratory 
tract in Malaysia. In addition, the 
distribution pattern changed in relation to 
ethnicity. In Chinese and Malay females, 
the prevalence of CC ranked second to 
breast cancer (BC) whereas the pattern 
was reversed in Indian females (Cheah & 
Looi 1999). 
BC is the most common form of 
malignancy among women worldwide, 
accounting for 21% of overall cancer 
diagnosis. It also caused the most deaths, 
with almost 50% dying from this disease 
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(Parkin 1998). Despite the fact that 
Malaysia had good treatment centers for 
reproductive cancer, mortality rates from 
BC and CC were high because of the 
failure of early detection. BC mortality rates 
have risen since 1985. Between 1993 and 
1996, 35% of the BC cases presented at 
stages 3 or 4, and 93% of these women 
had tumours with a mean size of 5.3cm 
(Hisham and Yip 2003). The reported 
incidence rate of BC in Malaysia appeared 
lower compared to other developed 
countries although the difference may be 
attributable to underreporting which could 
undermine efforts to acquire accurate 
figures. Worldwide, a 4-5 fold variation 
exist with the highest rates observed in 
Europe and North America and the lowest 
in Asia (Hisham and Yip 2003; Hisham & 
Yip 2004). 
Women between the ages of 40-59 have 
a 1 in 11 chance of developing some type 
of invasive cancers. In comparison, women 
from ages 1-39 have a 1 in 51 chance of 
being diagnosed with cancer. The most 
frequent cancers in Malaysian women were 
cancers of the breast, cervix, colon, ovary, 
leukaemias and lung. Together, cancers of 
the breast, cervix, ovary and corpus uteri, 
afflicting 30.4%, 12%, 5% and 3.6% 
respectively made up half  (51%) of all 
cancer cases (NCR 2002). Thus screening 
especially cancers of reproductive organs 
as women approached menopause 
becomes exceedingly important (Givens & 
Ling 2003). 
This study reports the incidence of breast 
and cervical cancers in a general 
population of urban women aged 45 years 
who volunteered in a lifestyle intervention 
program, with hopes of providing a health 
insight in these women. 
 
MATERIALS AND METHODS 
 
Data for this study was obtained from entry 
assessment of subjects who participated in 
a lifestyle intervention program. Briefly, 
healthy women aged 45 years and above 
with intact uterus, non HRT users were 
recruited from November 1999 to October 
2002 via distribution of flyers to residential 
areas around the hospital, including 
subjects from other areas who responded 
after being informed by friends. After an 
initial screening of 745 women by tele-
phone, 522 subjects were accepted into 
the study. Five women were later excluded 
for surgically induced menopause leaving 
only 517 subjects. 
Other exclusion criteria included preg-
nancy, immigrants, those on treatment for 
hypertension, diabetes mellitus, hyper-
lipidaemia and chronic illnesses. Those 
with secondary causes of osteoporosis 
such as a thyroid or endocrine condition 
e.g. Cushing’s disease, hyperthyroidism, 
hyperparathyroidism, malabsorption, hypo-
gonadism and prolonged immobilisation, 
were also excluded. The study protocol 
was approved by the hospital ethics 
committee as part of a Masters of O&G 
study thesis (Nur Azurah 2003). 
All subjects gave written informed 
consent before participation in the study. 
Recruits were interviewed for medical 
history and examined by a designated 
physician who also obtained cervical 
smears. Height and weight were measured 
to the nearest 0.1 unit with a balance beam 
weighing machine and stadiometer 
(Health-O-Meter, USA). Information 
acquired by questionnaires included 
personal characteristics and lifestyle. All 
activities were carried out in the general 
gynaecology clinic by trained personnel. 
Pap smears were taken by the attending 
physician on the first or second visit. After 
the first visit, 29 women were disqualified 
from the study upon discovery of illness 
needing medication (diabetes mellitus n=9, 
hypertension n=5, thyroid dysfunction n=1, 
severe osteoporosis n=1) or surgery 
(hysterectomy n=5, breast cancer n=6, 
thymus cancer n=1, nasopharyngeal 
cancer n=1).  Pap smears were not taken 
for 22 of these women. A mammogram by 
appointment was done 6-8 weeks after the 
initial visit in the radiology unit; 24 subjects 
were lost to follow up. The study reports a 
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total of 495 and 471 subjects for Pap 
smears and mammogram respectively with 
subjects followed up to year 2005.  
Data were analysed using SPSS for 
Windows version 11.0 software. 
Continuous variables were expressed as 
mean and standard deviation, and 
compared by the Student’s t test. 
Categorical data was compared using the 
Chi-squared test and relationships with 
Pearson or Spearman correlation where 
appropriate, followed by logistic regression 
analysis. The differences were considered 
significant if p<0.05.  
 
RESULTS 
 
Subject characteristics 
 
The average age of participants was 
51.27±5.35 years old (age range 45-79 
years). Over two thirds were Chinese 
followed by Malays and Indians, reflecting 
an urban distribution as opposed to the 
general population with Malays being the 
major ethnic entity. The study sample 
comprised of 300 (58.0%) premenopaused 
(age range 45-58 years) and 217 (42.0%) 
postmenopaused women (age range 45-79 
years), similarly distributed between the 
major ethnic groups (Table 1). The post-
menopausal group at mean age of 
55.53±5.27 years was 7.4 years older than 
those premenopausal, 48.14±2.67 years 
(p<0.0005). The mean and median age of 
menopause was 49.97±2.90 years and 
50.00 years respectively with no significant 
difference between the ethnic groups. 
Malays were the youngest, followed by 
Chinese, Indians and others with 
respective mean age of 50.14±4.33, 
51.51±5.53, 54.47±7.83 and 57.00±10.53, 
a significant difference (p=0.039). The 
average and median age of menarche was 
13.57±1.73 and 13.00 years old. Indians 
reaches menarche at 12.55±1.62 years; 
earlier than Malays, Chinese and others 
with a respective mean of 13.36±1.32, 
13.72±1.87 and 13.20±0.84 years 
(p<0.005). 
Table 1 : Sociodemographic, reproductive, lifestyle 
and anthropometric variables 
 
N=517 N (%) or 
Mean±sd 
Ethnic distribution  
Malay 143 (27.7) 
Chinese 347 (67.1) 
Indian 22 (4.3) 
Others 5 (1.0) 
Sociodemographics  
Age (yrs) 51.27±5.35 
 Age of menarche (yrs) 13.57±1.73 
Menopausal age (yrs) 49.97±2.90 
Income (RM) 3311±3141 
Education   
No formal schooling 21 (4.1) 
Primary level 113 (21.9) 
Secondary level  278 (53.8) 
College/tertiary level 104 (20.1) 
Unknown 1 (0.2) 
Marital status  
Married 401 (77.6) 
Widowed 47 (9.1) 
Never married/divorced 68 (13.1) 
Unknown 1 (0.2) 
Reproductive history  
Post-menopausal 217 (42.0) 
 Breastfed (n=449) 299 (66.6) 
Breastfeeding duration 
(month) 
11.14±24.60 
Ever user of OCP 197 (38.1) 
OCP duration (month) 19.29±42.83 
Pregnancy (Gravida=1 or 
more) 
450 (86.9) 
Parity (Para=1 or more, 
n=450) 
3.28±1.38 
Regular menses (before age 
35 yrs) 
456 (88.2) 
Days of menstrual cycle 27.93±2.95 
Lifestyle  
Never smoke 501 (96.9) 
Never drink alcohol 466 (90.1) 
Anthropometry  
Weight (kg) 59.41±9.50 
Height (m) 1.55±0.05 
Body mass index (kg/m2) 24.64±3.89 
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The mean height, weight and body mass 
index (BMI) of the sample population was 
1.55±0.05m, 59.41±9.50kg and 24.64± 
3.89kg/m2 respectively. The premeno-
pausal group was similar in weight, height 
and BMI to the postmenopausal group. 
Malays were the heaviest, 62.39±10.00kg 
with significantly higher BMI, 26.15± 
4.30kg/m2, compared to the others (both 
p<0.0005). Weight and BMI of Chinese, 
Indians and other races were 58.30± 
9.14kg, 58.03±7.75kg and 57.20±9.76kg; 
24.08±3.60kg/m2, 23.98±2.83kg/m2 and 
23.61±2.40kg/m2 respectively. Overall, 
56.3% had BMI between 18.5 to <25 
kg/m2, 32% were overweight and 8.6% 
obese.  
 
Cervical cytology 
 
Overall, over four fifths of women (83.5%) 
had normal Pap smear readings (Table 2). 
Abnormalities in Pap smear cytology were 
seen in 7.6% comprising 1.3% cervical 
intra-epithelial neoplasia (CIN), 6.1% HPV 
infection and 0.2% ASCUS. Yeast 
infections such as moniliasis and other 
organisms made up 8.9%.  
A 2.8 fold higher CIN grade 1 or 2 was 
demonstrated in postmenopaused women 
compared to the premenopaused, 2.1% vs. 
0.7% although not statistically significant. 
One premenopausal subject had atypical 
squamous cell of undetermined signifi-
cance (ASCUS) and required colposcopy. 
In contrast, premenopausal women had a 
higher infection rate compared to post-
menopaused, 11.3% vs. 4.2% respectively 
(p=0.024).  
One in seven (6.9%) had unsatisfactory 
smears, 3.9% versus 10.8% in pre and 
postmenopaused women respectively. 
Unsatisfactory smears were 2.8 fold higher 
among the postmenopaused due to 
atrophic vaginal changes. 
The distribution of abnormal cytology 
between the ethnic groups showed no 
significant difference. The occurrence of 
abnormal smears did not correlate with all 
the variables studied. The study data 
emphasised vigorous screening for 
carcinoma of the cervix to be implemented 
in postmenopausal women as the 
incidence of invasive CC was higher. 
 
Mammogram 
 
Over 90% of women had normal findings 
on mammogram while 39 (8.3%) showed 
some abnormalities (Table 3). In this study, 
6 (1.3%) had breast cancer, 17 (3.6%) 
required a biopsy while 16 (3.4%) needed 
regular follow up. The distribution of 
abnormalities differed between pre and 
postmenopaused women with post-
menopausal having more abnormal 
mammograms (p<0.0005) although the 
incidence of breast cancer (BC) was 
similar. In women with BC, one underwent 
total mastectomy while three had surgical 
removal of the lesion with one woman 
requiring chemotherapy. Two other cases 
were treated with tamoxifen.  
The overall detection rate for BC was 
less than 0.013. The rate of BC among 
premenopaused was 50% higher than in 
postmenopaused women (0.015 versus 
0.010) although it was not statistically 
significant. The distribution of abnormal 
mammograms between the ethnic groups 
showed no significant difference. Likewise, 
the rate of BC between Malays (0.016) and 
Chinese (0.012) was not significant 
statistically. Among Malay women, the BC 
rate was twice as high among the 
postmenopaused compared to pre-
menopaused while the reverse was 
observed among the Chinese.  
Most of the breast biopsies reported 
benign lesions and subjects were advised 
to have regular follow ups. A repeat 
mammography was advised for those with 
microcalcifications (n=12), macrocalci-
fication (n =1), benign nodules (n =2) and 
other structural abnormalities on the first 
mammogram. More premenopausal 
women (n=10) had dense or fibrous 
breasts compared to the postmenopaused 
although the difference was not significant. 
The occurrence of abnormal mammo-
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Table 2: Distribution of normal and abnormal cervical smears by menopausal status and ethnicity 
 
 All Malay Chinese Indian Others 
461 271 190 83 44 176 135 10 9 2 2 
N 
 PreM PosM PreM PosM PreM PosM PreM PosM PreM PosM 
Cytology diagnosis, n (%) 
Negative 
385 
(83.5) 
220 
(81.2) 
165 
(86.4) 
66 
(79.5) 
41 
(93.2) 
143 
(81.2) 
114 
(84.4) 
9 
(90.0) 
8 
(88.9) 
2 
(100.0) 
2 
(100.0) 
Benign 
Cellular 
Changes* 
41 
(8.9) 
32 
(11.8) 
9 
(4.7) 
10 
(12.0) 
2 
(4.5) 
22 
(12.5) 
6 
(4.4) 
- 
1 
(11.1) 
- - 
Candida 
32 
(6.9) 
17 
(6.3) 
5 
(2.6) 
8 
(9.6) 
2 
(4.5) 
19 
(10.8) 
3 
(2.2) 
- - - - 
Other 
infections 
9 
(1.9) 
5 
(1.8 ) 
4 
(2.1) 
2 
(2.4 ) 
- 
3 
(1.7) 
3 
(2.2) 
- 
1 
(11.1) 
- - 
Positive 
35 
(7.6 ) 
19 
(7.0 ) 
16 
(8.4) 
7 
(8.4 ) 
1 
(2.3 ) 
11 
(6.2) 
15 
(11.1) 
1 
(10.0) 
- - - 
ASCUS 
1 
(0.2 ) 
1 
(0.4 ) 
- - - 
1 
(0.6) 
- - - - - 
HPV 
28 
(6.1 ) 
16 
(5.9 ) 
12 
(6.3 ) 
7 
(8.4 ) 
- 
8 
(4.5) 
12 
(8.9) 
1 
(10.0) 
- - - 
CIN/Ca 
6 
(1.3 ) 
2 
(0.7) 
4 
(2.1 ) 
- 
1 
(2.3 ) 
2 
(1.1) 
3 
(2.2) 
- - - - 
Unsatisfactory 34 11 23 1 4 10 19 - - - - 
Total sampled 495 282 213 84 48 186 154 10 9 2 2 
*p<0.024 (comparison between pre and postmenopausal group) 
 
Table 3: Distribution of normal and abnormal mammograms by menopausal status and ethnicity 
 
 All Malay Chinese Indian Others 
471 268 203 84 43 171 150 10 9 3 1 
N 
 PreM PosM PreM PosM PreM PosM PreM PosM PreM PosM 
Radiology diagnosis, n (%) 
Normal 
432 
(91.7) 
250 
(93.3) 
182 
(89.7) 
78 
(92.9) 
37 
(86.0) 
159 
(93.0) 
135 
(90.0) 
10 
(100.0) 
9 
(100.0) 
3 
(100.0) 
2 
(100.0) 
Abnormal* 
39 
(8.3) 
18 
(6.7) 
21 
(10.3) 
6 
(7.1) 
6 
(14.0) 
12 
(7.0) 
15 
(10.0) 
- - - - 
Biopsy 
17 
(3.6) 
6 
(2.2) 
11 
(5.4) 
1 
(1.2) 
2 
(4.7) 
5 
(2.9) 
9 
(6.0) 
- - - - 
Follow-up 
16 
(3.4) 
8 
(3.0) 
8 
(3.9) 
4 
(4.8) 
3 
(7.0) 
4 
(2.3) 
5 
(3.3) 
- - - - 
Cancer 
6 
(1.3) 
4 
(1.5) 
2 
(1.0) 
1 
(1.2) 
1 
(2.3) 
3 
(1.8) 
1 
(0.7) 
- - - - 
*p<0.0005 (comparison between pre and postmenopausal group) 
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grams was positively associated with 
education (rho=0.120, p=0.009) and 
negatively with pregnancy (rho=-0.108, 
p=0.019). Pregnancy was categorized as 
never pregnant or pregnant, being defined 
as one or more pregnancies with or without 
live birth. Logistic regression analysis of 
both factors demonstrated a R2=0.037 
(p=0.013) but only education was signifi-
cant in the final model (R=0.115, p=0.018). 
Findings from this study seemed to 
concur with the Malaysian epidemiological 
data that the incidence rate of BC peaked 
earlier with a higher incidence among 
premenopausal women. Screening for 
breast abnormalities in perimenopausal 
women at and above 45 years old was 
definitely indicated from these findings in 
order to provide women with quality health. 
 
DISCUSSION 
 
The subjects in this study with an urban 
ethnic distribution, higher income and 
better education did not reflect middle aged 
Malaysian women in general. Furthermore, 
women who were highly motivated and 
health conscious volunteered to participate 
in this study. They could likely possess a 
better health status with lower risk factors 
for development of diseases, a bias of the 
recruitment process. Nevertheless, the 
data from this large study could be a useful 
reference for future research into the 
breast and cervical cancer incidences in 
this often neglected age group. 
 
Cervical cancer (CC) 
 
Postmenopausal women presented with a 
2.8 fold higher CIN grade 1 or 2 compared 
to the premenopaused, in concordance 
with epidemiological evidence. The 
detection rate of CIN was 1.3%, similar to 
the pickup rate of 1.4-1.8% in women age 
40 years and above, seen at UHKL over a 
5 year period (Lim 2002). Generally, the 
peak incidence of invasive cancer of the 
cervix was in the fifth and sixth decades of 
life (Parkin et al 1999; Wright et al 2002).  
Unsatisfactory smears were 2.8 fold more 
among the postmenopaused. This was 
attributed to atrophic changes of the vagina 
and cervix resulting in inadequate cells for 
cytology reporting. Improvement of the 
smear could be made by wetting the cervix 
with normal saline prior to the procedure. 
Although premenopausal women had 2.5 
fold higher infection rate compared to 
postmenopaused, a similar HPV infection 
rate was observed in both. HPV had been 
unequivocally recognized as the oncogenic 
agent causing dysplasia and CC in one 
third of all infected women (Parkin et al 
1999; Reeves at al 1989; Waxman 2005).  
Pathology data from HUKM supported the 
overall increasing trend of CC as CC 
mortality rates in Malaysia declined from 
1985 to 1993 and then increased in 1997 
(NCR 2002). The data also indicate that 
CC was manifesting at an earlier age. This 
could be due to lifestyle changes or earlier 
sexual activity in the younger group. 
Increasing incidence rate could possibly 
reflect higher public awareness of the 
disease and the initiative to seek medical 
attention. But a more likely scenario is the 
increasing prevalence of HPV infection, an 
aetiological factor in CC and the futility of 
sampling preinvasive lesions for 
adenocarcinoma (Adeeb et al 2007a).  
Overall the data supported screening to 
be provided to all women particularly aged 
40 and above as CC increased 
dramatically in women as they approached 
middle age. The study findings supported 
vigorous screening for CC which should be 
implemented in postmenopausal women as 
the incidence of malignancy was higher. 
Studies showed that approximately half of 
all women who died of cervical cancer had 
not had a Pap smear performed in the past 
five years. In countries where cervical 
smear screening was introduced, mortality 
rates from cervical cancer were reduced by 
80% (Waxman 2005). 
 
Breast Cancer (BC) 
 
In this study, the rate of new BC cases was
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6 per 471 women or 1273.9 per hundred 
thousand. For comparison, the incidence 
rate was 299.5 and 123.3 per hundred 
thousand for USA and Hong Kong 
respectively. It is recognised that case 
detection rate at the initiation of a 
screening program (i.e. first screening) 
tended to inflate the figures and did not 
reflect the true incidence rate of the 
general population (Leung et al 2002). 
From randomised trials, the highest 
detection rate at screening was 350 per 
hundred thousand in women aged 50 years 
and above (Miller et al 2000). Locally, the 
pick-up rate for new cases of breast 
diseases seen was 3.1% (Yip et al 1995). 
The possible explanation for the high figure 
in this study was the recruitment process 
whereby the subjects were self selected. 
These women were more health conscious 
and took the opportunity to avail 
themselves for a health examination upon 
participation. 
In the developed world, BC was seen 
mainly in the postmenopausal group (Bush 
et al 2001; Chlebowski et al 2003). In 
Malaysia, the peak prevalence age group 
was between 40-49 years old and the 
median age was 50 years, a phenomenon 
also observed in this study. Similarly, 
benign breast diseases formed the majority 
of breast diseases seen (Yip et al 1995). 
Data from the population-based Singapore 
Cancer Registry for 1968-1992 revealed an 
average annual increase of 3.6% over the 
25-year period for all women, from 20.2 per 
100,000 women in 1968-1972 to 38.8 per 
100,000 in 1988-1992. The rate of increase 
was highest in Malays (4.4%) and lowest in 
Indians (1.4%).  
From the small number of cases in this 
study, the significant predictor of abnormal 
mammograms was education. The 
association of education to abnormal 
mammograms emphasised the relationship 
that educated women will actively seek 
healthcare (Cheah & Looi 1999). 
Population trends indicated that incidence 
rates were likely to increase sharply in the 
future and suggested the role of 
demographic and lifestyle changes as 
possible risk factors (Seow et al 1996). 
Epidemiological factors associated with BC 
included increasing BMI, low physical 
activity, reproductive factors, diet, alcohol 
intake and hormone replacement therapy 
(Brewster & Helzlsouer 2001). Lifestyle 
practices such as breastfeeding offered a 
protection against breast cancer 
particularly among Chinese women in 
Klang valley, odds ratio 4.43 after 
adjustment for confounders (Hejar et al 
2004). 
Asian culture and women’s mentality 
constituted a major obstacle in promoting 
prevention of BC. Women were not 
empowered with the knowledge they need 
to seek preventive screening, and older 
women were difficult to reach or given 
information because they were unlikely to 
visit maternal-child health or family 
planning clinics (Anon 1997).  Studies had 
observed more advanced and larger 
tumours among Malays than other ethnic 
groups, mainly due to a later stage at 
presentation. The delay in presentation 
was attributed to a strong belief in 
traditional medicine, the negative 
perception of the disease, poverty and poor 
education, coupled with fear and denial 
(Hisham & Yip 2004). Cultural taboos 
prevented Malay women from examining 
their own bodies which resulted in denial of 
preventive care. Furthermore women fear 
their husbands would leave them after a 
mastectomy (Anon 1997). The availability 
of good health care and socioeconomic 
status of rural communities with limited 
health care facilities, lower education and 
poor income also influenced the 
presentation and detection of cancers. A 
higher risk for developing CC and 
prevalence pattern in ethnic Indians were 
partly a result of their socioeconomic 
deprivation (Cheah & Looi 1999).  
It should be made known that women with 
a first degree family history of BC had a 1.7 
fold increased risk of ovarian cancer (OC); 
an association with reciprocal ramifications. 
An increased risk of 2.2 fold was seen in 
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women with a first degree relative affected 
with OC. Corresponding risks of 7.1 to 10.7 
fold were observed for those with two or 
three affected relatives. Screening a 
population for OC with at least one first 
degree affected relative gave a prevalence 
of 3.8/1000 women. Screening women with 
BC/OC diseases gave a prevalence of 
50/1000 (Collins et al 1998). 
Malaysian women above 40 years should 
be offered and encouraged to have 
mammogram screening as an earlier peak 
prevalent age for BC was observed. 
Additionally, postmenopaused women 
were noted to have abnormal mammogram 
of a graver nature with 2.5 fold more 
requiring biopsies and 30% more needed 
regular follow ups. For this reason, a bi-
pronged approach could be advocated 
whereby younger women aged 40 years 
and above should have their first 
mammogram followed by a 5 year interval 
when the outcome was normal. Emphasis 
should be given for more frequent 
mammograms in those above 50 years old, 
possibly annually. 
In summary, cancers of the cervix and 
breast formed two fifths of all malignancies 
in women (NCR 2002) but more 
importantly, both diseases were amenable 
to measures for early detection and 
treatment. Hence in cancer prevention, 
health education to increase awareness, 
screening and early treatment could reduce 
the burden of both diseases (Lim 2002). 
The study supports screening for CC in 
postmenopausal women as the incidence 
of CIN and HPV was higher whereas 
mammogram screening should be offered 
and encouraged in women above 40 years 
as an earlier peak prevalent age for BC 
was observed. Pap smear, ultrasound of 
the pelvis and mammogram should be 
used synergistically with clinical judgment 
after completing a detailed history of risk 
factors and physical examination. With the 
wide use of pelvic ultrasound for imaging, 
endometrial thickness and ovarian volume 
normogram (Adeeb et al 2007b) should be 
made available for the local population to 
enable the clinician to tailor subsequent 
management and counselling. 
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